ALC-0315 - Wikipedia

Jump to content

Contents

move to sidebar hide

• (Top)
• 1 Synthesis
• 2 Use
• 3 See also
• 4 References

• Article
• Talk

English

• Read
• Edit
• View history

Tools Tools move to sidebar hide Actions

• Read
• Edit
• View history

General

• What links here
• Related changes
• Upload file
• Permanent link
• Page information
• Cite this page
• Get shortened URL
• Download QR code

Print/export

• Download as PDF
• Printable version

In other projects

• Wikidata item

Appearance move to sidebar hide From Wikipedia, the free encyclopedia ALC-0315

Names
Preferred IUPAC name [(4-Hydroxybutyl)azanediyl]di(hexane-6,1-diyl) bis(2-hexyldecanoate)
Identifiers
CAS Number	2036272-55-4 Y
3D model (JSmol)	Interactive image
ChemSpider	103867294 Y
PubChem CID	122666778
UNII	AVX8DX713V
CompTox Dashboard (EPA)	DTXSID701336663
InChI InChI=1S/C48H95NO5/c1-5-9-13-17-19-27-37-45(35-25-15-11-7-3)47(51)53-43-33-23-21-29-39-49(41-31-32-42-50)40-30-22-24-34-44-54-48(52)46(36-26-16-12-8-4)38-28-20-18-14-10-6-2/h45-46,50H,5-44H2,1-4H3Key: QGWBEETXHOVFQS-UHFFFAOYSA-N
SMILES CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCO)CCCCCCOC(=O)C(CCCCCC)CCCCCCCC
Properties
Chemical formula	C48H95NO5
Molar mass	766.290 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Chemical compound

ALC-0315 ([(4-hydroxybutyl)azanediyl]di(hexane-6,1-diyl) bis(2-hexyldecanoate)) is a synthetic lipid. A colorless oily material, it has attracted attention as a component of the SARS-CoV-2 vaccine, BNT162b2, from BioNTech and Pfizer. Specifically, it is one of four components that form lipid nanoparticles (LNPs), which encapsulate and protect the otherwise fragile mRNA that is the active ingredient in these drugs.[1][2] These nanoparticles promote the uptake of therapeutically effective nucleic acids such as oligonucleotides or mRNA both in vitro and in vivo.[3][4]

Below physiological pH, ALC-0315 becomes protonated at the nitrogen atom, yielding an ammonium cation that is attracted to the messenger RNA (mRNA), which is anionic.[5]

Synthesis

[edit]

The preparation of ALC-0315 was first described in a patent application to lipid nanoparticles by Acuitas Therapeutics in 2017.[6]: 137  The final step is a reductive amination reaction in which 4-aminobutanol is condensed with a lipid aldehyde, using sodium triacetoxyborohydride as the reducing agent to convert the intermediate imines to the amine of the product.

2 (C8H17)(C6H13)CHCO2(CH2)5CHO + H2N(CH2)4OH + 2 NaBH(O2CCH3)3 → ALC-0315

Use

[edit]

ALC-0315 is one of the components of the BNT162b2 vaccine (0.43 mg per dose).[7] Its chemical properties as a tertiary amine mean that its cation can form an ionic bond to the messenger RNA which carries the genetic information for the SARS-CoV-2 spike protein formation in the human body.[5] Importantly, once the lipid nanoparticle which encapsulates the mRNA has been absorbed into antigen-presenting cells (a process called receptor-mediated endocytosis) the more acidic environment within the endosome fully protonates the ALC-0315 as a result the nanoparticle releases its payload of mRNA.[2][8] In December 2021 there were objections raised against the use of ALC-0315 and ALC-0159 (and some other solid lipid nanoparticles) in humans by critics of mRNA-COVID-19 vaccines in Germany but the German pharmaceutical trade journal Pharmazeutische Zeitung (de) and the German investigative collective Correctiv refuted this and stated as one important reason that the European Medicines Agency has approved the vaccine and this includes all its ingredients.[9][10]

See also

[edit] Pfizer–BioNTech COVID-19 vaccine nanoparticle ingredients

• ALC-0159
• 1,2-distearoyl-sn-glycero-3-phosphocholine
• Cholesterol

References

[edit]

1. ^ Michael McCoy (February 12, 2021). "Lipids, the unsung COVID-19 vaccine component, Get Investment". Chemical and Engineering News.
2. ^ a b Ryan Cross (2021). "Without These Lipid Shells, There Would Be No mRNA Vaccines for COVID-19". Chemical & Engineering News: 16–19. doi:10.47287/cen-09908-feature1. S2CID 233842401.
3. ^ Sahin, Ugur; Karikó, Katalin; Türeci, Özlem (2014). "MRNA-based therapeutics — developing a new class of drugs". Nature Reviews Drug Discovery. 13 (10): 759–780. doi:10.1038/nrd4278. PMID 25233993. S2CID 27454546.
4. ^ Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.; Weissman, Drew (2018). "MRNA vaccines — a new era in vaccinology". Nature Reviews Drug Discovery. 17 (4): 261–279. doi:10.1038/nrd.2017.243. PMC 5906799. PMID 29326426.
5. ^ a b Medicines and Healthcare products Regulatory Agency (11 December 2020). "Public Assessment Report: Authorisation for Temporary Supply COVID-19 mRNA Vaccine BNT162b2" (PDF).
6. ^ WO application 2018081480, Ansell S.; Barbosa C. & Du X. et al., "Lipid nanoparticle formulations", published 2018-05-03, assigned to Acuitas Therapeutics, Inc. 
7. ^ Schoenmaker, Linde; Witzigmann, Dominik; Kulkarni, Jayesh A.; Verbeke, Rein; Kersten, Gideon; Jiskoot, Wim; Crommelin, Daan J. A. (2021-05-15). "mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability". International Journal of Pharmaceutics. 601 120586. doi:10.1016/j.ijpharm.2021.120586. ISSN 0378-5173. PMC 8032477. PMID 33839230.
8. ^ Chaudhary, Namit; Weissman, Drew; Whitehead, Kathryn A. (2021). "MRNA vaccines for infectious diseases: Principles, delivery and clinical translation". Nature Reviews Drug Discovery. 20 (11): 817–838. doi:10.1038/s41573-021-00283-5. PMC 8386155. PMID 34433919.
9. ^ "Absurde Diskussion um Lipide ALC-0315 und ALC-0159". 18 January 2022. Retrieved 23 January 2022. Erstens stimmt es nicht, dass die Zusatzstoffe unerlaubt sind. Denn Comirnaty ist zugelassen und damit sind auch alle darin enthaltenen Hilfsstoffe zugelassen. [Firstly, it is not true that the additives are illegal. Because Comirnaty is approved and therefore all the additives contained in it are also approved.]
10. ^ "Faktencheck: Nein, der Biontech-Impfstoff enthält keine Inhaltsstoffe, die nicht für Menschen zugelassen sind". 23 December 2021. Retrieved 23 January 2022. Doch anders als behauptet, sind sie nicht gesundheitsschädlich, die EMA hat die Impfung und somit auch deren Bestandteile zugelassen. Dass die Bestandteile bei der Zulassung der mRNA-Impfstoffe geprüft wurden, bestätigte uns auch das Paul-Ehrlich-Institut (PEI) auf Anfrage. [But contrary to what is claimed, they are not harmful to health, the EMA has approved the vaccination and thus also its components. On request, the Paul Ehrlich Institute (PEI) also confirmed that the components were tested when the mRNA vaccines were approved.]

Retrieved from "https://en.wikipedia.org/w/index.php?title=ALC-0315&oldid=1313919272" Categories:

• Esters
• Tertiary amines
• Lipids
• Primary alcohols

Hidden categories:

• Articles without InChI source
• Articles without EBI source
• Articles without KEGG source
• Articles containing unverified chemical infoboxes
• Articles with short description
• Short description matches Wikidata

Search Search Toggle the table of contents ALC-0315 10 languages Add topic